MedPath

Effectiveness of inhaled levodopa in Parkinson's disease

Conditions
Parkinson's diseaseZiekte van Parkinson
Registration Number
NL-OMON22984
Lead Sponsor
Department of Pharmaceutical Technology and Biopharmacy, Faculty of Mathematics and Natural Sciences, University of Groningen
Brief Summary

Can Patients with Parkinson’s Disease Use Dry Powder Inhalers during Off Periods? M. Luinstra, A. W. F. Rutgers, H. Dijkstra et al. Published: July 14, 2015. DOI: 10.1371/journal.pone.0132714 A levodopa dry powder inhaler for the treatment of Parkinson's disease patients in off periods. M. Luinstra, F. Grasmeijer, P. Hagedoorn et al. Eur J Pharm Biopharm. 2015 Oct 7. pii: S0939-6411(15)00404-X. doi: 10.1016/j.ejpb.2015.10.00

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
9
Inclusion Criteria

Diagnosed with Parkinson’s disease according to the UK Parkinson’s Disease Society Brain Bank Clinical Diagnostic Criteria;

At least 18 years of age;

Exclusion Criteria

Cognitive dysfunction, which precludes good understanding of instructions and/or informed consent;

Current treatment with apomorphine or duodopa by pump;

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Time until maximum effect on motor function (maximum change from baseline), determined by the MDS-UPDRS III test scores 3.3 Rigidity, 3.4 Finger tapping, 3.9 Arising from chair, and 3.10 Gait.
Secondary Outcome Measures
NameTimeMethod
Pharmacokinetic:<br /><br>Maximum levodopa concentration in plasma(Cmax).<br /><br>Time to maximum concentration (Tmax).<br /><br>Area under the concentration time (minutes) curve at 0-180 min (AUC0-180) after administration of the dose<br /><br>Pharmacodynamic:<br /><br>Finger tap count in 30 seconds (3.4 Finger tapping).<br /><br>The time it takes the patient to get up from a chair, walk 10 meters, turn around and walk back 10 meters (3.9 and 3.10 combined in timed up-and-go test). <br />
© Copyright 2025. All Rights Reserved by MedPath